Anup Challa

Anup Challa

AstraZeneca, Sweden - Södertälje / Sweden
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5583777
-
person_outline Anup Challa's MOST POPULAR ARTICLES
1-) Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialCT Bramante, JB Buse, DM Liebovitz, JM Nicklas, MA Puskarich, K Cohen, ...The Lancet Infectious Diseases 23 (10), 1119-1129, 20231042023
2-) Using what we already have: uncovering new drug repurposing strategies in existing omics dataJM Pulley, JP Rhoads, RN Jerome, AP Challa, KB Erreger, MM Joly, ...Annual review of pharmacology and toxicology 60 (1), 333-352, 2020532020
3-) Machine Learning on Drug-Specific Data to Predict Small Molecule TeratogenicityAP Challa, AL Beam, M Shen, T Peryea, RR Lavieri, ES Lippmann, ...Reproductive Toxicology, 2020202020
4-) Systematically Prioritizing Candidates in Genome-Based Drug RepurposingAP Challa, RR Lavieri, JT Lewis, NM Zaleski, JK Shirey-Rice, PA Harris, ...ASSAY and Drug Development Technologies 17 (8), 352-363, 2019152019
5-) Human and Machine Intelligence Together Drive Drug Repurposing in Rare DiseasesAP Challa, NM Zaleski, RN Jerome, RR Lavieri, JK Shirey-Rice, ...Frontiers in Genetics 12, 2021132021